Metagenomi Therapeutics, Inc. (MGX) › Net IncomeMetagenomi Therapeutics, Inc. (MGX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2023: -$68.25M2024: -$78.06M2025: -$87.87M-$87.87M2023Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$87.87M-12.6%2024-$78.06M-14.4%2023-$68.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share